
You may wonder if you can use Botox and Aimovig together if you suffer from chronic migraine headaches. This article will cover the benefits and side effects of these medications. Botox was also approved by The American Academy of Neurology. In fact, the two drugs are recommended to treat migraine headaches together. However, they can cause serious side effects.
Side effects of Aimovig
Both botox injections and Aimovig were not directly tested in clinical studies. However, both drugs have been shown to be effective in the treatment of chronic migraine headaches. 40% of chronic migraine patients experienced fewer headache days after three months of treatment. Compared to nonusers, Botox reduced headache days by an average of 9.2 days per month over 24 weeks. Both medications are brand-named, but neither is generic.
Side effects of Aimovig or botosx can be minor but serious complications could occur. If you experience serious side effects, however, they are very rare, you should contact your doctor immediately. Aimovig can lead to an increase in blood pressure if your blood pressure is high. Your doctor might recommend a different medication, or another treatment.

Botox Side Effects
You might be curious about what to expect during an injection of aimovig. Botox can be administered to patients at the doctor's office every 12 weeks. The procedure involves 31 tiny injections. Botox is a different treatment than Aimovig, but both have similar side-effects. A botox injection can help with migraines.
There are few side effects associated with botox injections, but the potential for muscle weakness, eyelid ptosis, and neck pain is real. Although these side effects typically disappear within a few days, they can affect compliance. In addition, Botox treatment requires regular injections every 12 weeks. The injections can be painful and require a cold compress for a few days.
Side effects of CGRP-mAbs
Side effects of CGRP inhibitions have been observed in a handful of clinical trials. But they are not widespread. Many patients were also affected by other inflammatory comorbidities. Some even experienced an unexpected aggravation of an already existing disease. Although some patients were deemed 'at-risk', this is still uncertain. A cautious approach has been taken due to the lack of information about drug-drug interactions among CGRP inhibitors with other inflammatory comorbidities. This risk group must be known by physicians to ensure safe use of CGRP inhibitors. Patient registries will also be needed to identify patients at high risk.
CGRP Abs can cause severe flares of arthritic or psoriasis. There are two phases to inflammatory processes in psoriasis. During this initiating phase, keratinocytes secrete probiotic peptides that stimulate plasmacytoid diedritic cells. These peptides encourage myeloid dendritic cell maturation and differentiation into TH1 cells and TH17. Activated dendritic cells move to lymph nodes and promote inflammation.

Side effects of combination therapies
Botox is a prescription drug used to treat migraine headaches. Aimovig can be administered intramuscularly once every 12 months. Both medications have similar side effect profiles. Combined, they can cause serious side effects. If you're interested in trying one of these drugs, you should consult with your doctor to find out if this combination is right for you. Be aware of the possible side effects for each treatment.
Botox, an FDA-approved treatment to treat migraines, is available for adults. It requires at most 31 injections. The procedure is repeated every 3 months. While the side effects are rare, temporary muscle weakness or decreased compliance can occur. It also reduces neurotransmitters, such as CGRP. If combined with botox, there is a risk of muscle weakness.